Back to search

Gene Signatures of Progression and Metastasis in Renal Cell Cancer

Data up to Jan 2025

Published2005
Citations429
References59

Total Citations Per Year

Abstract

References (59)

TNM Classification of Malignant Tumours

1987 • 16,209 citations

Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring

1999 • 11,586 citations

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2000 • 9,712 citations

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

2002 • 6,428 citations

Numerical Taxonomy: The Principles and Practice of Numerical Classification

1973 • 5,043 citations

TNM Classification of Malignant Tumours

2003 • 3,865 citations

Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection

2000 • 3,126 citations

A molecular signature of metastasis in primary solid tumors

2002 • 2,424 citations

Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

2001 • 1,690 citations

A Stem Cell Molecular Signature

2002 • 1,553 citations

Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL

2003 • 864 citations

THE CHANGING NATURAL HISTORY OF RENAL CELL CARCINOMA

2001 • 848 citations

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

2002 • 759 citations

Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial Neoplasms

2002 • 711 citations

Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.

1997 • 693 citations

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors

2003 • 611 citations

Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma.

2000 • 438 citations

Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification

2001 • 408 citations

STAGE SPECIFIC GUIDELINES FOR SURVEILLANCE AFTER RADICAL NEPHRECTOMY FOR LOCAL RENAL CELL CARCINOMA

1998 • 342 citations

Angiopoietin-Like 4 Is a Proangiogenic Factor Produced during Ischemia and in Conventional Renal Cell Carcinoma

2003 • 323 citations

Gene Expression Patterns in Renal Cell Carcinoma Assessed by Complementary DNA Microarray

2003 • 262 citations

Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data

2003 • 262 citations

Identification and Classification of Differentially Expressed Genes in Renal Cell Carcinoma by Expression Profiling on a Global Human 31,500-Element cDNA Array

2001 • 209 citations

Expression Levels of Genes that Regulate Metastasis and Angiogenesis Correlate with Advanced Pathological Stage of Renal Cell Carcinoma

2001 • 195 citations

Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.

2003 • 182 citations

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers

2003 • 181 citations

Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor

2003 • 179 citations

Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization

2001 • 149 citations

Imatinib Mesylate (Gleevec) Inhibits Ovarian Cancer Cell Growth through a Mechanism Dependent on Platelet-Derived Growth Factor Receptor α and Akt Inactivation

2004 • 117 citations

Gene Expression in Kidney Cancer Is Associated with Cytogenetic Abnormalities, Metastasis Formation, and Patient Survival

2005 • 93 citations

Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma

2003 • 90 citations

Expression of Platelet-Derived Growth Factor-AA is Associated with Tumor Progression in Osteosarcoma

2003 • 84 citations

Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells

2004 • 83 citations

Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase.

2003 • 78 citations

Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy.

2001 • 77 citations

Permutation-validated principal components analysis of microarray data

2002 • 71 citations

Dual Mechanisms for Lysophosphatidic Acid Stimulation of Human Ovarian Carcinoma Cells

2003 • 70 citations

THE DIAGNOSTIC VALUE OF BONE SCAN IN PATIENTS WITH RENAL CELL CARCINOMA

2001 • 69 citations

Differential protein profiling in renal‐cell carcinoma

2004 • 65 citations

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS PREDICTS BONE METASTASIS IN PATIENTS PRESENTING WITH RENAL CELL CARCINOMA: IMPLICATION FOR PREOPERATIVE BONE SCANS

2004 • 61 citations

ZD1839 Modulates Paclitaxel Response in Renal Cancer by Blocking Paclitaxel-Induced Activation of the Epidermal Growth Factor Receptor–Extracellular Signal-Regulated Kinase Pathway

2004 • 60 citations

Histopathological analysis of angiogenic factors in renal cell carcinoma

2003 • 58 citations

Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome

2004 • 54 citations

mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas

2001 • 49 citations

Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma?

1999 • 45 citations

Recurrence of renal cell carcinoma more than 5 years after nephrectomy

2002 • 45 citations

Genes@Work: an efficient algorithm for pattern discovery and multivariate feature selection in gene expression data

2004 • 43 citations

Involvement of adrenomedullin induced by hypoxia in angiogenesis in human renal cell carcinoma

2002 • 39 citations

Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma?

1999 • 37 citations

Phase II Trial of Pegylated-Liposomal Doxorubicin (Doxil™) in Mesothelioma

2002 • 33 citations

Prognostic factors and molecular markers for renal cell carcinoma

2001 • 29 citations

Serum levels of some acute phase proteins in kidney and urinary tract urothelial cancers

1997 • 23 citations

Sialylated glycoconjugates in chromophobe cell renal carcinoma compared with other renal cell tumors

1992 • 23 citations

Renal Chromophobe Cell Carcinoma: Limitations of Paraffin-Embedded Tissue

1993 • 22 citations

The significance of thymidine phosphorylase/platelet‐derived endothelial cell growth factor activity in renal cell carcinoma

2003 • 20 citations

Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-Roussy.

1988 • 15 citations

POU domain genes are differentially expressed in the early stages after lineage commitment of the PNS-derived stem cell line, RT4-AC

1998 • 7 citations

A Combination of Vinblastine and Doxorubicin with Interferon Alpha

1996 • 5 citations

The activity of topoisomerases is related to the grade and stage in human renal cell carcinoma.

1994 • 4 citations

Cited By (0)

No citing papers found in database

Gene Signatures of Progression and Metastasis in Renal Cell Cancer (2005) – Clinical Cancer Research | Metascience Observatory Explorer